ONE-WAYOngoing theme · still written in the latest filings
A business model linking early partnering revenue to royalty revenue
A revenue model based on partnering with pharmaceutical companies and others at an early stage of research and development, generating upfront payments, R&D collaboration funding and development milestone payments, and ultimately leading to royalty income after product launch.
Companies19How many companies write about this.
Threads26One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps25 helps · 1 hurts · 0 flat